CNS Pharmaceuticals, Inc. Assets, Noncurrent
CNS Pharmaceuticals, Inc. (CNSP) had Assets, Noncurrent of $15.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AssetsNoncurrent · last filed 2026-08-12
- 2026-06-30: Assets, Noncurrent $15.00K.
- 2026-03-31: Assets, Noncurrent $574.85K.
- 2025-12-31: Assets, Noncurrent $521.00K; Assets, Noncurrent as first filed $520.66K.
- 2025-09-30: Assets, Noncurrent $477.52K.
| Period end | Assets, Noncurrent | Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $15.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $574.85K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $521.00K 10-Q · filed 2026-08-12 | $520.66K 10-K · filed 2026-03-31 |
| 2025-09-30 | $477.52K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $370.06K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $27.29K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $42.44K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $21.18K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $323.87K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $59.60K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $109.68K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $266.20K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $380.58K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $442.52K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $488.47K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $937.56K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.05M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $1.14M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $1.28M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $351.66K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $355.03K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $358.24K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $357.57K 10-K · filed 2022-03-03 | |
| 2020-09-30 | $469.06K 10-Q · filed 2020-11-12 | |
| 2019-12-31 | $18.16K 10-K · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |